Think Bioscience Appoints Nicholas A. Saccomano, Ph.D., to its Board of Directors

Think Bioscience bolsters drug development expertise and deepens relationship with Colorado life science ecosystem following a $17M financing. BOULDER, Colo., Sept. 6, 2022 /PRNewswire/ — Think Bioscience (“Think”), a Boulder-based synthetic biology company focused on developing…

Click here to view original post